「Taiwan Lung Cancer Clinical Trial Consortium (TALCC)」is a non-profit research alliance focusing on lung cancer clinical trials and researches collaboration. The purpose of TALCC is to share the clinical data and research achievements. The vision of TALCC is to advance Taiwan to be one of the leading countries for the international lung cancer clinical trials and new drug application, which aims to provide the patients with newly available drugs in light of the up-to-date new drug developments. By way of integrating with the database of the clinical data, bio-specimen and bio-markers to share with all members and to initial researches is the goal of TALCC.


The major tasks of TALCC are (1) to develop a platform sharing the clinical trial related data and information for research collaboration and publications; (2) to promote the international research collaboration, to hold the international symposiums and to provide the members with the information and opportunities for participating in the international clinical trials.

Contact Us

「Taiwan Lung Cancer Clinical Trial Consortium」Secretariat

Professor James Chih-Hsin Yang

Telephone No.:886-2-23123456 ext. 66588